Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection Fraction

Volume: 14, Issue: 4, Pages: 525 - 535
Published: Oct 1, 2018
Abstract
More than 50% of patients with clinical heart failure have a preserved ejection fraction. Despite mortality that is similar to or slightly lower than heart failure with reduced ejection fraction, trials to date have not shown a therapy that imparts a mortality benefit in heart failure with preserved ejection fraction (HFpEF). HFpEF represents a heterogeneous disorder with a complex pathophysiologic basis, and this may contribute to the negative...
Paper Details
Title
Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection Fraction
Published Date
Oct 1, 2018
Volume
14
Issue
4
Pages
525 - 535
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.